Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 93-17-4 | MDL No. : | MFCD00001911 |
Formula : | C10H11NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ASLSUMISAQDOOB-UHFFFAOYSA-N |
M.W : | 177.20 | Pubchem ID : | 66727 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 48.95 |
TPSA : | 42.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.56 cm/s |
Log Po/w (iLOGP) : | 1.99 |
Log Po/w (XLOGP3) : | 1.15 |
Log Po/w (WLOGP) : | 1.77 |
Log Po/w (MLOGP) : | 1.13 |
Log Po/w (SILICOS-IT) : | 2.16 |
Consensus Log Po/w : | 1.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.81 |
Solubility : | 2.77 mg/ml ; 0.0156 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.63 |
Solubility : | 4.14 mg/ml ; 0.0233 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.14 |
Solubility : | 0.128 mg/ml ; 0.000723 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With 5% Pd/C; ammonia; hydrogen In toluene at 160℃; for 19 h; Industrial scale | 3,4-Dimethoxy-cyanobenzyl 110kg) and toluene (450 l, 3percent palladium on carbon catalyst 1.5kg put together in 3000 l reactor, while passing ammonia gas into 5.5kg, was heated to 160 deg.] C, hydrogen gas was slowly about after 16 hours, maintaining the internal reactor pressure 1.0MPa, etc. within the reactor pressure no longer decreased pressure and temperature for another three hours to complete the reaction, after the reaction to cool relief, the catalyst was filtered off, the solvent evaporated under reduced pressure to remove toluene to give 91percent product 3,4-dimethoxy phenethylamine, total yield 91percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With sodium ethanolate In ethanolReflux | 5-(4-Hydroxypiperidin-1-yl)-thiophene-2-carboxaldehyde and 3,4-dimethoxybenzyl cyanide were placed in a reactor and dissolved in ethanol. Sodium ethoxide was added thereto, and the mixture was stirred under reflux. After completion of reaction, the reaction mixture was cooled for tens of minutes with a flow of water. Water was added to the cooled mixture, and stirring was performed for tens of minutes. The precipitated crystals were recovered through filtration and washed sequentially with water, ethanol, and hexane, followed by drying under reduced pressure, to thereby yield (Z)-2-(3,4-dimethoxy-phenyl)-3-[5-(4-hydroxy-piperidin-1-yl)-thiophen-2-yl]-acrylonitrile. By use of 5-bromothiophene-2-carboxaldehyde (42.30 g) and 4-hydroxypiperidine (67.30 g), amine incorporation was performed according to Production Step 1, to thereby yield 5-(4-hydroxy-piperidin-1-yl)-thiophene-2-carboxaldehyde (yield: 33.00 g, 71percent). The thus-produced 5-(4-hydroxy-piperidin-1-yl)-thiophene-2-carboxaldehyde (10.56 g) and 3,4-dimethoxybenzyl cyanide (8.86 g) were subjected to condensation according to Production Step 2, to thereby yield (Z)-2-(3,4-dimethoxy-phenyl)-3-[5-(4-hydroxy-piperidin-1-yl)-thiophen-2-yl]-acrylonitrile (yield: 13.50 g, 73percent). The thus-produced (Z)-2-(3,4-dimethoxy-phenyl)-3-[5-(4-hydroxy-piperidin-1-yl)-thiophen-2-yl]-acrylonitrile (20.00 g) was dissolved in chloroform (650 mL), and the solution was reacted with pyridine (6.41 g) and bromoacetyl bromide (14.13 g) according to Production Step 3 (Method A), to thereby yield bromo-acetic acid 1-[5-[(Z)-2-cyano-2-(3,4-dimethoxy-phenyl)-vinyl]-thiophen-2-yl]-piperidin-4-yl ester (yield: 23.00 g, 87percent). The thus-produced bromo-acetic acid 1-[5-[(Z)-2-cyano-2-(3,4-dimethoxy-phenyl)-vinyl]-thiophen-2-yl]-piperidin-4-yl ester (2.30 g) was dissolved in chloroform (100 mL), and the solution was reacted with piperidine (533 mg) and triethylamine (658 mg) according to Production Step 4, to thereby yield the title compound (yield: 1.40 g, 60percent). |
[ 13338-63-1 ]
3,4,5-Trimethoxyphenylacetonitrile
Similarity: 0.91
[ 262298-02-2 ]
4-Methoxy-2-methylphenylacetonitrile
Similarity: 0.90
[ 19924-43-7 ]
2-(3-Methoxyphenyl)acetonitrile
Similarity: 0.90
[ 52805-46-6 ]
3-Hydroxy-4-methoxybenzonitrile
Similarity: 0.88
[ 13338-63-1 ]
3,4,5-Trimethoxyphenylacetonitrile
Similarity: 0.91
[ 262298-02-2 ]
4-Methoxy-2-methylphenylacetonitrile
Similarity: 0.90
[ 19924-43-7 ]
2-(3-Methoxyphenyl)acetonitrile
Similarity: 0.90
[ 35202-54-1 ]
4,5-Dimethoxy-1-cyanobenzocyclobutane
Similarity: 0.89
[ 13338-63-1 ]
3,4,5-Trimethoxyphenylacetonitrile
Similarity: 0.91
[ 262298-02-2 ]
4-Methoxy-2-methylphenylacetonitrile
Similarity: 0.90
[ 19924-43-7 ]
2-(3-Methoxyphenyl)acetonitrile
Similarity: 0.90
[ 35202-54-1 ]
4,5-Dimethoxy-1-cyanobenzocyclobutane
Similarity: 0.89